AU2005278323B2 - Prostaglandin derivatives for treating gastrointestinal disorder - Google Patents

Prostaglandin derivatives for treating gastrointestinal disorder Download PDF

Info

Publication number
AU2005278323B2
AU2005278323B2 AU2005278323A AU2005278323A AU2005278323B2 AU 2005278323 B2 AU2005278323 B2 AU 2005278323B2 AU 2005278323 A AU2005278323 A AU 2005278323A AU 2005278323 A AU2005278323 A AU 2005278323A AU 2005278323 B2 AU2005278323 B2 AU 2005278323B2
Authority
AU
Australia
Prior art keywords
administered
hydrogen
halogen
prostaglandin compound
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2005278323A
Other languages
English (en)
Other versions
AU2005278323A1 (en
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35229739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2005278323(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Publication of AU2005278323A1 publication Critical patent/AU2005278323A1/en
Application granted granted Critical
Publication of AU2005278323B2 publication Critical patent/AU2005278323B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
AU2005278323A 2004-09-02 2005-09-01 Prostaglandin derivatives for treating gastrointestinal disorder Expired AU2005278323B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US60652104P 2004-09-02 2004-09-02
US60/606,521 2004-09-02
US66631705P 2005-03-30 2005-03-30
US60/666,317 2005-03-30
US66659305P 2005-03-31 2005-03-31
US60/666,593 2005-03-31
PCT/JP2005/016464 WO2006025599A1 (en) 2004-09-02 2005-09-01 Prostaglandin derivatives for treating gastrointestinal disorder

Publications (2)

Publication Number Publication Date
AU2005278323A1 AU2005278323A1 (en) 2006-03-09
AU2005278323B2 true AU2005278323B2 (en) 2011-03-17

Family

ID=35229739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005278323A Expired AU2005278323B2 (en) 2004-09-02 2005-09-01 Prostaglandin derivatives for treating gastrointestinal disorder

Country Status (16)

Country Link
US (2) US8748481B2 (cg-RX-API-DMAC7.html)
EP (1) EP1791545B1 (cg-RX-API-DMAC7.html)
JP (4) JP2008511541A (cg-RX-API-DMAC7.html)
KR (4) KR20070048221A (cg-RX-API-DMAC7.html)
CN (1) CN102885821A (cg-RX-API-DMAC7.html)
AR (1) AR050626A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005278323B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514891A (cg-RX-API-DMAC7.html)
CA (1) CA2577284A1 (cg-RX-API-DMAC7.html)
ES (1) ES2603381T3 (cg-RX-API-DMAC7.html)
IL (1) IL181332A (cg-RX-API-DMAC7.html)
MX (1) MX2007002602A (cg-RX-API-DMAC7.html)
NO (1) NO340989B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ553434A (cg-RX-API-DMAC7.html)
TW (1) TWI387454B (cg-RX-API-DMAC7.html)
WO (1) WO2006025599A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1562604E (pt) * 2002-10-23 2012-04-09 Sucampo Ag Compostos de prostaglandina para o tratamento de obesidade
EP1641462B1 (en) * 2003-07-03 2010-11-24 Sucampo AG Enteric coated composition comprising prostaglandin analogs as chloride channel opener
EP1984027B1 (en) 2006-01-24 2015-12-30 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
CA2870252A1 (en) * 2012-04-23 2013-10-31 Sucampo Ag Method for treating irritable bowel syndrome with diarrhea
AU2014213251B2 (en) * 2013-02-04 2017-07-20 Taisho Pharmaceutical Co., Ltd. Prophylactic or therapeutic drug for constipation
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
WO2003030912A1 (en) * 2001-08-31 2003-04-17 Sucampo Ag Prostaglandin analogs as chloride channel opener
WO2004060377A1 (en) * 2002-12-27 2004-07-22 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5380709A (en) 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
JP4332316B2 (ja) 1999-10-15 2009-09-16 スキャンポ・アーゲー 二環式化合物組成物およびその安定化方法
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
PT1389116E (pt) 2001-05-18 2008-04-11 Sucampo Ag Composição de indução catártica
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
EP1641462B1 (en) 2003-07-03 2010-11-24 Sucampo AG Enteric coated composition comprising prostaglandin analogs as chloride channel opener

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
WO2003030912A1 (en) * 2001-08-31 2003-04-17 Sucampo Ag Prostaglandin analogs as chloride channel opener
WO2004060377A1 (en) * 2002-12-27 2004-07-22 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Drugs of the Future, 2004, 29(4): 336-341 *

Also Published As

Publication number Publication date
CN102885821A (zh) 2013-01-23
ES2603381T3 (es) 2017-02-27
US8748481B2 (en) 2014-06-10
TWI387454B (zh) 2013-03-01
AR050626A1 (es) 2006-11-08
IL181332A0 (en) 2007-07-04
NZ553434A (en) 2010-01-29
NO340989B1 (no) 2017-07-31
JP6408426B2 (ja) 2018-10-17
KR20070048221A (ko) 2007-05-08
US20060063830A1 (en) 2006-03-23
AU2005278323A1 (en) 2006-03-09
JP2008511541A (ja) 2008-04-17
BRPI0514891A (pt) 2008-06-24
KR20170003712A (ko) 2017-01-09
KR20180033310A (ko) 2018-04-02
EP1791545B1 (en) 2016-08-31
WO2006025599A1 (en) 2006-03-09
MX2007002602A (es) 2007-04-25
JP2018150354A (ja) 2018-09-27
JP2015166377A (ja) 2015-09-24
NO20071704L (no) 2007-05-31
EP1791545A1 (en) 2007-06-06
JP2013049688A (ja) 2013-03-14
US20140315994A1 (en) 2014-10-23
CA2577284A1 (en) 2006-03-09
IL181332A (en) 2015-09-24
KR20140019006A (ko) 2014-02-13
TW200612901A (en) 2006-05-01

Similar Documents

Publication Publication Date Title
US8389542B2 (en) Dosage unit comprising a prostaglandin analog for treating constipation
US20140315994A1 (en) Method for treating gastrointestinal disorder
DE60218451T2 (de) 15-ketoprostaglandin-verbindung zur behandlung von azrneimittelinduzierter verstopfung
AU2003292556B2 (en) Derivatives of prostaglandins for treating abdominal discomfort
US10561649B2 (en) Pharmaceutical combination of opioid and prostaglandin compound
RU2392941C2 (ru) Производные простагландинов для лечения желудочно-кишечного нарушения
US20130281526A1 (en) Method for treating irritable bowel syndrome with diarrhea
HK1155649B (en) Dosage unit comprising a prostaglandin analog for treating constipation

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired